Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ernest J. Moore"'
Autor:
James E. Baumgartner, Linda S. Baumgartner, Michael E. Baumgartner, Ernest J. Moore, Steven A. Messina, Michael D. Seidman, David R. Shook
Publikováno v:
Stem Cells Translational Medicine, Vol 10, Iss 2, Pp 164-180 (2021)
Abstract While cell therapies hold remarkable promise for replacing injured cells and repairing damaged tissues, cell replacement is not the only means by which these therapies can achieve therapeutic effect. For example, recent publications show tha
Externí odkaz:
https://doaj.org/article/88a7c5b80e5c494e92c2d0876de391ac
Autor:
Linda S. Baumgartner, Michael E. Baumgartner, David Shook, Steven A. Messina, Michael D. Seidman, Ernest J. Moore, James E. Baumgartner
Publikováno v:
Stem Cells Translational Medicine, Vol 10, Iss 2, Pp 164-180 (2021)
Stem Cells Translational Medicine
Stem Cells Translational Medicine
While cell therapies hold remarkable promise for replacing injured cells and repairing damaged tissues, cell replacement is not the only means by which these therapies can achieve therapeutic effect. For example, recent publications show that treatme
Autor:
Ernest J. Moore, Mary Clare Day, James E. Baumgartner, Michael D. Seidman, Jennifer Greif Green, David Shook, Steven A. Messina, Rajesh Nandy, Linda S. Baumgartner
Publikováno v:
Journal of Audiology & Otology
BACKGROUND AND OBJECTIVES Sensorineural hearing loss (SNHL) in children is associated with neurocognitive morbidity. The cause of SNHL is a loss of hair cells in the organ of Corti. There are currently no reparative treatments for SNHL. Numerous stud
Publikováno v:
European Journal of Pharmacology. 794:92-99
Gentamicin is an aminoglycoside antibiotic that is used in clinical, organismic, and agricultural applications to combat gram-negative, aerobic bacteria. The clinical use of gentamicin is widely linked to various toxicities, but there is a void in ou
Publikováno v:
European Journal of Pharmacology. 667:188-194
Tinnitus affects approximately 50 million people in the USA alone, with 10 million being highly debilitated. Pharmacotherapy for tinnitus is still in emerging stages due to time consuming clinical trials and/or animal experiments. We tested a new cel
Publikováno v:
ORL. 67:75-82
Potassium M currents play a role in stabilizing the resting membrane potential. These currents have previously been identified in several cell types, including sensory receptors. Given that maintaining membrane excitability is important for mechano-e
Publikováno v:
European journal of pharmacology. 732
A novel class of drugs - potassium (K(+)) channel openers or activators - has recently been shown to cause anticonvulsive and neuroprotective effects by activating hyperpolarizing K(+) currents, and therefore, may show efficacy for treating tinnitus.
Publikováno v:
Journal of neural transmission (Vienna, Austria : 1996). 121(7)
Antioxidants are well known for their neuroprotective properties against reactive oxygen species in cortical neurons and auditory cells. We recently identified L-carnitine and D-methionine to be among agents that provide such protection. Here, we inv
Autor:
Mohamed Hersi, Thomas J. Lukas, Kyle Laster, Kanishk Sharma, Calvin Wu, Christina Torres, Ernest J. Moore
Publikováno v:
BMC Physiology
Background KCNQx genes encode slowly activating-inactivating K+ channels, are linked to physiological signal transduction pathways, and mutations in them underlie diseases such as long QT syndrome (KCNQ 1), epilepsy in adults (KCNQ 2/3), benign famil